Graft characteristics for the study patients
Parameter . | N . | Median (range) . | Mean ± SD . |
|---|---|---|---|
| Unmanipulated UCB infusion | |||
| Cryopreserved MNCs, × 107/kg | 28 | 6.74 (2.31-18.34) | 7.90 ± 4.31 |
| UCB MNCs, × 107/kg | 28 | 2.05 (1.10-5.53) | 2.63 ± 1.21 |
| CD 34+ cells, × 105/kg | 26 | 0.78 (0.02-15.99) | 1.60 ± 3.12 |
| CD 3+ cells, × 106/kg | 26 | 5.27 (1.32-16.63) | 5.76 ± 3.48 |
| CFU-GMs, × 104/kg | 28 | 0.67 (0.10-9.50) | 1.25 ± 1.79 |
| Ex vivo-expanded UCB infusion | |||
| UCB MNCs, × 107/kg | 28 | 2.05 (0.06-10.19) | 2.86 ± 2.73 |
| CD 34+ cells, × 105/kg | 28 | 0.22 (0.001-2.59) | 0.49 ± 0.59 |
| CFU-GMs, × 104/kg | 26 | 35.56 (0.11-184.32) | 61.52 ± 63.51 |
Parameter . | N . | Median (range) . | Mean ± SD . |
|---|---|---|---|
| Unmanipulated UCB infusion | |||
| Cryopreserved MNCs, × 107/kg | 28 | 6.74 (2.31-18.34) | 7.90 ± 4.31 |
| UCB MNCs, × 107/kg | 28 | 2.05 (1.10-5.53) | 2.63 ± 1.21 |
| CD 34+ cells, × 105/kg | 26 | 0.78 (0.02-15.99) | 1.60 ± 3.12 |
| CD 3+ cells, × 106/kg | 26 | 5.27 (1.32-16.63) | 5.76 ± 3.48 |
| CFU-GMs, × 104/kg | 28 | 0.67 (0.10-9.50) | 1.25 ± 1.79 |
| Ex vivo-expanded UCB infusion | |||
| UCB MNCs, × 107/kg | 28 | 2.05 (0.06-10.19) | 2.86 ± 2.73 |
| CD 34+ cells, × 105/kg | 28 | 0.22 (0.001-2.59) | 0.49 ± 0.59 |
| CFU-GMs, × 104/kg | 26 | 35.56 (0.11-184.32) | 61.52 ± 63.51 |
MNC indicates mononuclear cell.